C
Cytokinetics, Incorporated (CYTK)
NMS – Real Time Price. Currency in USD
74.81
+0.25 (0.34%)
At close: May 12, 2026, 4:00 PM EDT
75.32
+0.51 (0.68%)
Pre-market: May 13, 2026, 4:01 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
74.81
+0.25 (0.34%)
At close: May 12, 2026, 4:00 PM EDT
75.32
+0.51 (0.68%)
Pre-market: May 13, 2026, 4:01 AM EDT
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
| Name | Position |
|---|---|
| Dr. Fady Ibraham Malik FACC, M.D., Ph.D. | Executive Vice President of Research & Development |
| Dr. James A. Spudich Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Dr. James H. Sabry M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| Mr. Andrew M. Callos | Executive VP & Chief Commercial Officer |
| Mr. Jeff Lotz | Vice President of Sales & Operations |
| Mr. Jeffrey J. Hessekiel J.D. | Executive VP, Chief Legal & Administrative Officer |
| Mr. Robert I. Blum | CEO, President & Director |
| Mr. Steven M. Cook J.D. | Senior Vice President of Global Supply Chain Operations & Technical Operations |
| Mr. Sung H. Lee | EVP & CFO |
| Ms. Holly Laughlin | VP of Accounting & Corporate Controller |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 8-K | d138544d8k.htm |
| 2026-04-17 | DEF 14A | ny20063687x771_def14a.htm |
| 2026-04-17 | ARS | ny20063687x772_ars.pdf |
| 2026-02-26 | S-8 | d18277ds8.htm |
| 2026-02-26 | 10-K | cytk-20251231.htm |
| 2026-02-24 | 8-K | cytk-20260224.htm |
| 2026-02-17 | 8-K | cytk-20260217.htm |
| 2025-12-19 | 8-K | cytk-20251219.htm |
| 2025-12-12 | 8-K | cytk-20251212.htm |
| 2025-11-14 | 8-K | cytk-20251113.htm |